JAMDA
August 14, 2014
Showing 51 - 60 of 2825 results
JAMDA
January 28, 2021
Cognition-Enhancing, Antipsychotic, and Opioid Medication Use Among Assisted Living and Residential Care Residents in Oregon
Explore community- and resident-level characteristics associated with polypharmacy and use of cognition-enhancing, antipsychotic, and opioid medications among a statewide representative sample of assisted living and residential care (AL/RC) residents.
JAMDA
June 8, 2024
Prevalence and Correlates of Antipsychotic Medication Use in Oregon Assisted Living
Investigate how assisted living and residential care (AL/RC) and memory care (MC) contexts are associated with the 90-day prevalence of antipsychotic medication use (APU), considered a quality measure in long-term care.
JAMDA
August 5, 2025
Potentially High-Risk Antipsychotic Use in People With Dementia: A National Data Linkage Study
To investigate the prevalence of and sociodemographic factors associated with potentially high-risk antipsychotic use in people living with dementia in Australia.
JAMDA
September 24, 2016
Perceptions of Gown and Glove Use to Prevent Methicillin-resistant Transmission in Nursing HomesStaphylococcus aureusPerceptions of Gown and Glove Use to Prevent Methicillin-resistant Transmission in Nursing Homes
To explore current use and perceptions of glove and gown use in nursing homes.
JAMDA
June 22, 2018
Antipsychotic Deprescription for Older Adults in Long-term Care: The HALT Study
Despite limited efficacy and significant safety concerns, antipsychotic medications are frequently used to treat behavioral and psychological symptoms of dementia (BPSD) in long-term residential care. This study evaluates the sustained reduction of antipsychotic use for BPSD through a deprescribing interve...
JAMDA
February 21, 2018
Reduction of Unnecessary Usage of Antipsychotics, Physical Altercations and Falls in Memory Care Units by Implementing Person Centered Comfort Care
JAMDA
April 13, 2025
Agreement of Medicare Part D and Minimum Data Set Reported Psychotropic Medication Use in Nursing Homes
Little evidence exists on the accuracy of the Minimum Data Set (MDS)–based medication items. We compared quarterly rates of antipsychotic, antidepressant, and hypnotic use between the MDS and Part D Prescription Drug Event file (PDE) in 2018.
JAMDA
December 24, 2020
Geographic Variation in Anticoagulant Use and Resident, Nursing Home, and County Characteristics Associated With Treatment Among US Nursing Home Residents
To quantify geographic variation in anticoagulant use and explore what resident, nursing home, and county characteristics were associated with anticoagulant use in a clinically complex population.
JAMDA
February 22, 2023